Royalty Pharma: We Continue To Like The Strategy And Sell-Off Is Overdone (NASDAQ:RPRX) seekingalpha.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from seekingalpha.com Daily Mail and Mail on Sunday newspapers.
Competition is heating up in the microbiome niche as UK-based biotech Microbiotica raised €60M (£50M) in a Series B round to advance two candidates designed to treat cancer and ulcerative colitis.